Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

TSRI Laboratories Perform Crucial Research in Development of Promising Ebola Virus Treatment

07.08.2014

Laboratories at The Scripps Research Institute (TSRI) are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus.

The conditions of two Americans have reportedly improved since they received a highly experimental antibody cocktail called ZMapp, supplied by San Diego-based Mapp Biopharmaceutical.


Photo courtesy of The Scripps Research Institute.

Scripps Research Institute Professor Erica Ollmann Saphire heads a consortium to find the best antibody cocktail to treat deadly Ebola virus infections.

The TSRI laboratories of Professor Erica Ollmann Saphire and Assistant Professor Andrew Ward are studying the structures of these antibodies using techniques called electron microscopy, which creates high-resolution images by hitting samples with electrons, and X-ray crystallography, which determines the atomic structure of crystalline arrays of proteins.

Through these images, the team will discover exactly how the immune system molecules bind to the Ebola virus and stop it from functioning, a critical step in drug development.

... more about:
»Ebola »Health »Scripps »TSRI »Vaccine »Virus »laboratories

Ebola virus causes an extremely virulent disease that currently leads to death in 25 to 90 percent of cases. The fast-moving virus is spread via the blood or other bodily fluids of an infected person,

“What we’re showing are sites of vulnerability on the surface of the virus,” said C. Daniel Murin, a graduate student in the Saphire and Ward labs. “These are the chinks in the armor of the virus and the places were you would want your anti-serum to target.”

The ZMapp treatment is still in experimental stages and has not yet been approved for use outside the two recent cases. According to Saphire, ZMapp is one of the best antibody cocktails currently known, but there may still be ways to improve it. She is currently leading a $28 million National Institutes of Health-funded consortium to test antibody cocktails from laboratories around the world, with the goal of finding the best for neutralizing Ebola virus and the many other viruses like it.

An ideal antibody cocktail would ease symptoms and improve the prognosis of infected individuals—it could even work as a preventative measure, protecting healthcare workers before they enter an infected area.

The work on the Ebola virus is part of a larger Vaccine and Global Health Initiative at TSRI, which includes research on HIV/AIDS, influenza and tuberculosis.

More:

1. Outsmarting Viruses: A Profile of Erica Ollmann Saphire
http://www.scripps.edu/newsandviews/e_20140512/ollmann-saphire.html

2. Video: Creating a Roadmap for New Treatments
https://www.youtube.com/watch?v=eEtu-TPPR2A&list=UUYZkc-c8pRYOb-45g52Gegg

3. Consortium Wins Up to $28 Million to Find Best Ebola Treatment
http://www.scripps.edu/newsandviews/e_20140324/ollmann_saphire.html

4. TSRI’s Vaccine and Global Health Initiative
http://www.scripps.edu/philanthropy/pdfs/vaccines.pdf

About the Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.

Contact Information

Mika Ono
mikaono@scripps.edu
858-784-2052

Mika Ono | newswise

Further reports about: Ebola Health Scripps TSRI Vaccine Virus laboratories

More articles from Life Sciences:

nachricht From rigid to flexible
29.08.2016 | Technische Universität Dresden

nachricht Moth takes advantage of defensive compounds in Physalis fruits
26.08.2016 | Max-Planck-Institut für chemische Ökologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Streamlining accelerated computing for industry

PyFR code combines high accuracy with flexibility to resolve unsteady turbulence problems

Scientists and engineers striving to create the next machine-age marvel--whether it be a more aerodynamic rocket, a faster race car, or a higher-efficiency jet...

Im Focus: X-ray optics on a chip

Waveguides are widely used for filtering, confining, guiding, coupling or splitting beams of visible light. However, creating waveguides that could do the same for X-rays has posed tremendous challenges in fabrication, so they are still only in an early stage of development.

In the latest issue of Acta Crystallographica Section A: Foundations and Advances , Sarah Hoffmann-Urlaub and Tim Salditt report the fabrication and testing of...

Im Focus: Piggyback battery for microchips: TU Graz researchers develop new battery concept

Electrochemists at TU Graz have managed to use monocrystalline semiconductor silicon as an active storage electrode in lithium batteries. This enables an integrated power supply to be made for microchips with a rechargeable battery.

Small electrical gadgets, such as mobile phones, tablets or notebooks, are indispensable accompaniments of everyday life. Integrated circuits in the interiors...

Im Focus: UCI physicists confirm possible discovery of fifth force of nature

Light particle could be key to understanding dark matter in universe

Recent findings indicating the possible discovery of a previously unknown subatomic particle may be evidence of a fifth fundamental force of nature, according...

Im Focus: Wi-fi from lasers

White light from lasers demonstrates data speeds of up to 2 GB/s

A nanocrystalline material that rapidly makes white light out of blue light has been developed by KAUST researchers.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

The energy transition is not possible without Geotechnics

25.08.2016 | Event News

New Ideas for the Shipping Industry

24.08.2016 | Event News

A week of excellence: 22 of the world’s best computer scientists and mathematicians in Heidelberg

12.08.2016 | Event News

 
Latest News

3-D-printed structures 'remember' their shapes

29.08.2016 | Materials Sciences

From rigid to flexible

29.08.2016 | Life Sciences

Sensor systems identify senior citizens at risk of falling within 3 weeks

29.08.2016 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>